Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Theranexus Société Anonyme
  6. Company
    ALTHX   FR0013286259

THERANEXUS SOCIÉTÉ ANONYME

(ALTHX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Theranexus SA is a France-based company engaged in the healthcare industry. The Company is a biopharmaceutical entity that develops drug candidates to be used in the treatment of central nervous system (CNS) disorders, including epilepsy, narcolepsy, Parkinson's disease, Alzheimer's disease, neuropathic pain and psychiatric disorders. Its patented technology is aimed at increasing the efficacy of CNS drugs, which are approved and available on the market. The Company's technology is protected, scalable and versatile, and used to generate high value-added proprietary drug candidates for different conditions, while reducing time-to-market and market entry costs and risks in comparison with standard drug development processes. Theranexus SA operates in the domestic market.

Number of employees : 17 people.
Managers
NameAgeSinceTitle
Franck Joseph Louis Mouthon-2013Chairman & Chief Executive Officer
Thierry Bertrand Lambert--Chief Financial & Administrative Officer
Mathieu Bernard Mari Charveriat, Dr.-2013Director, Chief Scientific Officer & Deputy CEO
Werner Rein, Dr.-2017Chief Medical Officer
Dominique Costantini, Dr.-2017Independent Director
Luc-André Granier, Dr.-2017Independent Director
Jérôme Martinez, Dr.592018Independent Director
Rodolphe Besserve-2018Independent Director
Julien Veys-2016Chief Business Development Officer
Members of the board
NameAgeSinceTitle
Franck Joseph Louis Mouthon-2013Chairman & Chief Executive Officer
Mathieu Bernard Mari Charveriat, Dr.-2013Director, Chief Scientific Officer & Deputy CEO
Dominique Costantini, Dr.-2017Independent Director
Luc-André Granier, Dr.-2017Independent Director
Florian Denis-2017Director
Jérôme Martinez, Dr.592018Independent Director
Rodolphe Besserve-2018Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,087,437 2,958,335 72.4% 0 0.0% 72.4%
Shareholders
NameEquities%
Auriga Partners SA 577,762 14.1%
Supernova Invest SAS 393,078 9.63%
Mathieu Bernard Mari Charveriat 317,776 7.78%
Franck Joseph Louis Mouthon 317,776 7.78%
Ostrum Asset Management SA 204,062 5.00%
Kreaxi SASU 124,738 3.05%
Richard Platford 96,884 2.37%
Financière Arbevel SA 84,990 2.08%
Keren Finance SAS 24,186 0.59%
Gestys SA 12,500 0.31%
Company contact information
Theranexus SA
60, avenue Rockefeller
Pépinière Laennec
Lyon, Auvergne-Rhone-Alpes 69008

Phone : +33.1.53.67.36.75
Web : http://www.theranexus.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Theranexus Société Anonyme
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
THERANEXUS SOCIÉTÉ ANONYME-38.02%56
GILEAD SCIENCES, INC.14.33%83 541
WUXI APPTEC CO., LTD.24.70%63 775
REGENERON PHARMACEUTICALS11.35%55 705
BIONTECH SE160.57%51 304
VERTEX PHARMACEUTICALS-20.52%48 628
BEIGENE, LTD.24.54%29 784
GENMAB A/S10.52%28 359
ARGENX SE10.41%16 252
HUALAN BIOLOGICAL ENGINEERING INC.-14.44%10 217
NEUROCRINE BIOSCIENCES, INC.4.87%9 504
DENALI THERAPEUTICS INC.-11.97%8 936
ARROWHEAD PHARMACEUTICALS, INC.11.61%8 914
MIRATI THERAPEUTICS, INC.-24.17%8 568
REMEGEN CO., LTD.34.63%8 070
ACCELERON PHARMA INC.0.23%7 784
ASCENDIS PHARMA A/S-15.49%7 587
FATE THERAPEUTICS, INC.-11.77%7 544
EXELIXIS, INC.11.66%7 023
GW PHARMACEUTICALS PLC89.72%6 907
AKESO, INC.62.63%6 504
Connections : Theranexus Société Anonyme